Health Care & Life Sciences » Pharmaceuticals | Consun Pharmaceutical Group Ltd.

Consun Pharmaceutical Group Ltd. | Mutual Funds

Mutual Funds that own Consun Pharmaceutical Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
11,326,044
1.29%
-8,933,044
0%
12/31/2017
Jupiter China Fund
3,491,000
0.4%
3,491,000
1.85%
02/28/2018
DFA Emerging Markets Core Equity Portfolio
3,148,000
0.36%
845,000
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
2,863,000
0.33%
410,000
0.04%
01/31/2018
Jupiter Global Emerging Markets Fund
2,388,000
0.27%
2,388,000
1.51%
02/28/2018
Nomura Asset Asia Brand Equity Mother Fund
2,234,269
0.26%
-468,590
2.67%
06/07/2017
1,860,000
0.21%
1,860,000
1.19%
02/28/2018
Lazard Emerging Markets Equity Blend Portfolio
1,634,000
0.19%
392,000
0.41%
07/31/2018
WisdomTree Emerging Markets Small Cap Dividend Fund
1,557,000
0.18%
0
0.09%
09/06/2018
CREF Stock Account
1,535,000
0.18%
0
0%
03/31/2018

About Consun Pharmaceutical Group

View Profile
Address
71 Dong Peng Avenue, Eastern Section
Guangzhou Guangdong 510760
China
Employees -
Website http://www.chinaconsun.com
Updated 07/08/2019
Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.